» Articles » PMID: 35992877

Growth-promoting Function of the CGAS-STING Pathway in Triple-negative Breast Cancer Cells

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Aug 22
PMID 35992877
Authors
Affiliations
Soon will be listed here.
Abstract

The cGAS-STING axis is one of the key mechanisms guarding cells from pathogen invasion in the cytoplasmic compartment. Sensing of foreign DNA in the cytosol by the cGAS-STING axis triggers a stress cascade, culminating at stimulation of the protein kinase TBK1 and subsequently activation of inflammatory response. In cancer cells, aberrant metabolism of the genomic DNA induced by the hostile milieu of tumor microenvironment or stresses brought about by cancer therapeutics are the major causes of the presence of nuclear DNA in the cytosol, which subsequently triggers a stress response. However, how the advanced tumors perceive and tolerate the potentially detrimental effects of cytosolic DNA remains unclear. Here we show that growth limitation by serum starvation activated the cGAS-STING pathway in breast cancer cells, and inhibition of cGAS-STING resulted in cell death through an autophagy-dependent mechanism. These results suggest that, instead of being subject to growth inhibition, tumors exploit the cGAS-STING axis and turn it to a survival advantage in the stressful microenvironment, providing a new therapeutic opportunity against advanced cancer. Concomitant inhibition of the cGAS-STING axis and growth factor signaling mediated by the epidermal growth factor receptor (EGFR) synergistically suppressed the development of tumor organoids derived from primary tumor tissues of triple-negative breast cancer (TNBC). The current study unveils an unexpected function of the cGAS-STING axis in promoting cancer cell survival and the potential of developing the stress-responding pathway as a therapeutic target, meanwhile highlights the substantial concerns of enhancing the pathway's activity as a means of anti-cancer treatment.

Citing Articles

A novel TREX1 inhibitor, VB-85680, upregulates cellular interferon responses.

Flowers S, Petronella B, McQueney M, Fanelli B, Eisenberg W, Uveges A PLoS One. 2024; 19(8):e0305962.

PMID: 39178223 PMC: 11343403. DOI: 10.1371/journal.pone.0305962.


The Role of cGAS-STING in Age-Related Diseases from Mechanisms to Therapies.

Zheng W, Feng D, Xiong X, Liao X, Wang S, Xu H Aging Dis. 2023; 14(4):1145-1165.

PMID: 37163421 PMC: 10389832. DOI: 10.14336/AD.2023.0117.


The Role of Patient-Derived Organoids in Triple-Negative Breast Cancer Drug Screening.

Psilopatis I, Mantzari A, Vrettou K, Theocharis S Biomedicines. 2023; 11(3).

PMID: 36979752 PMC: 10045189. DOI: 10.3390/biomedicines11030773.

References
1.
da Silva J, Nunes N, Izetti P, Gomes de Mesquita G, de Melo A . Triple negative breast cancer: A thorough review of biomarkers. Crit Rev Oncol Hematol. 2020; 145:102855. DOI: 10.1016/j.critrevonc.2019.102855. View

2.
Arakawa S, Tsujioka M, Yoshida T, Tajima-Sakurai H, Nishida Y, Matsuoka Y . Role of Atg5-dependent cell death in the embryonic development of Bax/Bak double-knockout mice. Cell Death Differ. 2017; 24(9):1598-1608. PMC: 5563990. DOI: 10.1038/cdd.2017.84. View

3.
Rabinowitz J, White E . Autophagy and metabolism. Science. 2010; 330(6009):1344-8. PMC: 3010857. DOI: 10.1126/science.1193497. View

4.
Mizushima N, Yoshimori T, Ohsumi Y . The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol. 2011; 27:107-32. DOI: 10.1146/annurev-cellbio-092910-154005. View

5.
Pal S, Childs B, Pegram M . Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat. 2010; 125(3):627-36. PMC: 3244802. DOI: 10.1007/s10549-010-1293-1. View